401 related articles for article (PubMed ID: 8711101)
1. Preventing perinatal transmission of HIV--costs and effectiveness of a recommended intervention.
Gorsky RD; Farnham PG; Straus WL; Caldwell B; Holtgrave DR; Simonds RJ; Rogers MF; Guinan ME
Public Health Rep; 1996; 111(4):335-41. PubMed ID: 8711101
[TBL] [Abstract][Full Text] [Related]
2. Economic impact of treatment of HIV-positive pregnant women and their newborns with zidovudine. Implications for HIV screening.
Mauskopf JA; Paul JE; Wichman DS; White AD; Tilson HH
JAMA; 1996 Jul; 276(2):132-8. PubMed ID: 8656505
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of interventions to reduce vertical HIV transmission from pregnant women who have not received prenatal care.
Mrus JM; Tsevat J
Med Decis Making; 2004; 24(1):30-9. PubMed ID: 15005952
[TBL] [Abstract][Full Text] [Related]
4. HIV infection and zidovudine use in childbearing women.
Sia J; Paul S; Martin RM; Cross H
Pediatrics; 2004 Dec; 114(6):e707-12. PubMed ID: 15545619
[TBL] [Abstract][Full Text] [Related]
5. Incremental cost-effectiveness of two zidovudine regimens to prevent perinatal HIV transmission in the United States.
Pinkerton SD; Holtgrave DR; Layde PM
Prev Med; 2000 Jan; 30(1):64-9. PubMed ID: 10642461
[TBL] [Abstract][Full Text] [Related]
6. Reducing perinatal HIV transmission in developing countries through antenatal and delivery care, and breastfeeding: supporting infant survival by supporting women's survival.
Berer M
Bull World Health Organ; 1999; 77(11):871-7. PubMed ID: 10612882
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV.
Pinkerton SD; Holtgrave DR; Pinkerton HJ
Arch Intern Med; 1997 Sep; 157(17):1972-80. PubMed ID: 9308509
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of short-course zidovudine to prevent perinatal HIV type 1 infection in a sub-Saharan African Developing country setting.
Mansergh G; Haddix AC; Steketee RW; Nieburg PI; Hu DJ; Simonds RJ; Rogers M
JAMA; 1996 Jul; 276(2):139-45. PubMed ID: 8656506
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness estimates for antenatal HIV testing in the Netherlands.
Rozenbaum MH; Verweel G; Folkerts DK; Dronkers F; van den Hoek JA; Hartwig NG; de Groot R; Postma MJ
Int J STD AIDS; 2008 Oct; 19(10):668-75. PubMed ID: 18824618
[TBL] [Abstract][Full Text] [Related]
10. Preventing HIV infection in infants and children by reducing perinatal HIV transmission: review of efficacy and preliminary cost evaluation. South Carolina Pediatric AIDS Advisory Committee.
Johnson GM
J S C Med Assoc; 1996 Mar; 92(3):121-7. PubMed ID: 8881607
[No Abstract] [Full Text] [Related]
11. Evidence-based guidelines for universal counselling and offering of HIV testing in pregnancy in Canada.
Samson L; King S
CMAJ; 1998 Jun; 158(11):1449-57. PubMed ID: 9629106
[TBL] [Abstract][Full Text] [Related]
12. Update: perinatally acquired HIV/AIDS--United States, 1997.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1997 Nov; 46(46):1086-92. PubMed ID: 9385878
[TBL] [Abstract][Full Text] [Related]
13. From research to practice: use of short course zidovudine to prevent mother-to-child HIV transmission in the context of routine health care in Northern Thailand.
Thaineua V; Sirinirund P; Tanbanjong A; Lallemant M; Soucat A; Lamboray JL
Southeast Asian J Trop Med Public Health; 1998 Sep; 29(3):429-42. PubMed ID: 10437936
[TBL] [Abstract][Full Text] [Related]
14. U.S. Public Health Service recommendations for human immunodeficiency virus counseling and voluntary testing for pregnant women.
Pediatr AIDS HIV Infect; 1995 Dec; 6(6):397-406. PubMed ID: 11361465
[TBL] [Abstract][Full Text] [Related]
15. From the Centers for Disease Control and Prevention. Progress toward elimination of perinatal HIV infection--Michigan, 1993-2000.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2002 Feb; 51(5):93-7. PubMed ID: 11892955
[TBL] [Abstract][Full Text] [Related]
16. Economic evaluation of HIV screening in pregnant women attending antenatal clinics in India.
Kumar M; Birch S; Maturana A; Gafni A
Health Policy; 2006 Jul; 77(2):233-43. PubMed ID: 16126300
[TBL] [Abstract][Full Text] [Related]
17. Preventing perinatal HIV transmission: zidovudine use during pregnancy.
Carmichael C
Am Fam Physician; 1997 Jan; 55(1):171-4, 177-8. PubMed ID: 9012276
[TBL] [Abstract][Full Text] [Related]
18. Operational issues in preventing mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire, 1998-99.
Msellati P; Hingst G; Kaba F; Viho I; Welffens-Ekra C; Dabis F
Bull World Health Organ; 2001; 79(7):641-7. PubMed ID: 11477967
[TBL] [Abstract][Full Text] [Related]
19. Administration of zidovudine during late pregnancy and delivery to prevent perinatal HIV transmission--Thailand, 1996-1998.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1998 Mar; 47(8):151-4. PubMed ID: 9518278
[TBL] [Abstract][Full Text] [Related]
20. The president's fiscal year 2007 initiative for human immunodeficiency virus counseling and testing expansion in the United States: a scenario analysis of its coverage, impact, and cost-effectiveness.
Holtgrave DR
J Public Health Manag Pract; 2007; 13(3):239-43. PubMed ID: 17435490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
